Invention Grant
- Patent Title: Inhibition of BMP signaling, compounds, compositions and uses thereof
-
Application No.: US16353745Application Date: 2019-03-14
-
Publication No.: US10745400B2Publication Date: 2020-08-18
- Inventor: Corey R. Hopkins , Matthew Ritter , Charles C. Hong , Anish Vadukoot , Darren W. Engers , Craig W. Lindsley
- Applicant: Vanderbilt University
- Applicant Address: US TN Nashville US CA San Diego
- Assignee: Vanderbuilt University,La Jolla Pharmaceuticals Company
- Current Assignee: Vanderbuilt University,La Jolla Pharmaceuticals Company
- Current Assignee Address: US TN Nashville US CA San Diego
- Agency: Stites & Harbison PLLC
- Agent Richard S. Myers, Jr.
- Main IPC: C07D471/10
- IPC: C07D471/10 ; A61K31/438 ; C07D471/04 ; A61P35/00
Abstract:
Provided herein are substituted imidazo[1,2-a]pyridines useful as inhibitors of BMP signaling. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted imidazo[1,2-a]pyridines.
Public/Granted literature
- US20190284183A1 INHIBITION OF BMP SIGNALING, COMPOUNDS, COMPOSITIONS AND USES THEREOF Public/Granted day:2019-09-19
Information query
